Alnylam’s Qfitlia receives FDA nod for haemophilia A and B treatment
Qfitlia is approved for routine prophylaxis in individuals aged 12 and older, both adults and children, with haemophilia A or B, regardless of the presence of factor VIII or IX...
Scinai to acquire Pincell for its rare skin disease drug PC111
Genmab’s Tivdak approved in Japan to treat cervical cancer
Bio-Thera partners with Dr. Reddy’s for commercialisation of proposed biosimilars
Merck’s pneumococcal vaccine Capvaxive approved in EU
Exelixis obtains expanded FDA approval for Cabometyx to treat NET
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry